Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

194 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Regression of paclitaxel-induced maculopathy with oral acetazolamide.
Meyer KM, Klink T, Ugurel S, Bröcker EB. Meyer KM, et al. Among authors: Ugurel S. Graefes Arch Clin Exp Ophthalmol. 2012 Mar;250(3):463-4. doi: 10.1007/s00417-011-1642-8. Epub 2011 Mar 23. Graefes Arch Clin Exp Ophthalmol. 2012. PMID: 21431400 No abstract available.
Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma.
O'Day SJ, Eggermont AM, Chiarion-Sileni V, Kefford R, Grob JJ, Mortier L, Robert C, Schachter J, Testori A, Mackiewicz J, Friedlander P, Garbe C, Ugurel S, Collichio F, Guo W, Lufkin J, Bahcall S, Vukovic V, Hauschild A. O'Day SJ, et al. Among authors: Ugurel S. J Clin Oncol. 2013 Mar 20;31(9):1211-8. doi: 10.1200/JCO.2012.44.5585. Epub 2013 Feb 11. J Clin Oncol. 2013. PMID: 23401447 Clinical Trial.
[Treatment of advanced metastatic melanoma].
Ugurel S, Becker JC. Ugurel S, et al. Hautarzt. 2011 Jun;62(6):423-9. doi: 10.1007/s00105-010-2041-5. Hautarzt. 2011. PMID: 21533654 Review. German.
Melanoma.
Schadendorf D, van Akkooi ACJ, Berking C, Griewank KG, Gutzmer R, Hauschild A, Stang A, Roesch A, Ugurel S. Schadendorf D, et al. Among authors: Ugurel S. Lancet. 2018 Sep 15;392(10151):971-984. doi: 10.1016/S0140-6736(18)31559-9. Lancet. 2018. PMID: 30238891 Review.
Non-reproducible sequence artifacts in FFPE tissue: an experience report.
Ofner R, Ritter C, Ugurel S, Cerroni L, Stiller M, Bogenrieder T, Solca F, Schrama D, Becker JC. Ofner R, et al. Among authors: Ugurel S. J Cancer Res Clin Oncol. 2017 Jul;143(7):1199-1207. doi: 10.1007/s00432-017-2399-1. Epub 2017 Mar 17. J Cancer Res Clin Oncol. 2017. PMID: 28314930
Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC.
Becker JC, Stang A, Hausen AZ, Fischer N, DeCaprio JA, Tothill RW, Lyngaa R, Hansen UK, Ritter C, Nghiem P, Bichakjian CK, Ugurel S, Schrama D. Becker JC, et al. Among authors: Ugurel S. Cancer Immunol Immunother. 2018 Mar;67(3):341-351. doi: 10.1007/s00262-017-2099-3. Epub 2017 Nov 30. Cancer Immunol Immunother. 2018. PMID: 29188306 Free PMC article. Review.
Merkel cell carcinoma: recent insights and new treatment options.
Schrama D, Ugurel S, Becker JC. Schrama D, et al. Among authors: Ugurel S. Curr Opin Oncol. 2012 Mar;24(2):141-9. doi: 10.1097/CCO.0b013e32834fc9fe. Curr Opin Oncol. 2012. PMID: 22234254 Review.
Merkel cell carcinoma: molecular pathogenesis, clinical features and therapy.
Becker JC, Kauczok CS, Ugurel S, Eib S, Bröcker EB, Houben R. Becker JC, et al. Among authors: Ugurel S. J Dtsch Dermatol Ges. 2008 Sep;6(9):709-19. doi: 10.1111/j.1610-0387.2008.06830.x. J Dtsch Dermatol Ges. 2008. PMID: 19000060 Review. English, German.
The incidence of this rare tumor is increasing rapidly; the American Cancer Society estimates for 2008 almost 1500 new cases in the U.S. ...
The incidence of this rare tumor is increasing rapidly; the American Cancer Society estimates for 2008 almost 1500 new cases in the U.S
194 results
Jump to page
Feedback